retatrutide latest clinical trial results Results: 24% Weight Loss in 48 Weeks retatrutide clinical trials results 9
Description
A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy
AC: adenylate cyclase
Retatrutide Status Retatrutide remains in Phase 3 clinical trials with FDA approval projected for late 2026 to early 2027
doi: 10.1111/bph.15576
However, the half-life of GLP-1 is too short at 1 to 2 minutes, making it difficult to use as a drug [21]
2000;528(Pt 1):165176
